Non-Small Cell Lung Cancer
Desired tumor response achieved in phase 2 non-small cell lung cancer trial
Published in AIDS Weekly, May 23rd, 2005
This trial evaluates talabostat in combination with docetaxel in patients with stage IIIb/IV NSCLC who have failed a platinum-based therapy.
"I am very excited about the positive results we have seen in this study. These results allow us to move forward in planning our phase 3 pivotal program for NSCLC, which we intend to initiate later this year," said Dr. Maggie Uprichard, senior vice president and chief development officer at Point.
...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
Source: AIDS Weekly (2005-05-23)
More Articles from AIDS Weekly
- HIV-2 Exposure
High HIV-2-specific T cell activity in HIV-2-exposed uninfected/infected persons - HIV/AIDS Drug Development
Molecular modeling reveals new HIV-1 IN binding site for nucleotide inhibitor - HIV/AIDS Surveillance
"Detuned" HIV immunoassay detects infections missed by surveillance methods - HIV/AIDS Vaccine
T cell vaccine might work against high- but not low-dose HIV exposure - Business & Finance
COLD-EEZE maker reports financial results - Business & Finance
Pharmaceutical company reports first quarter 2005 financial results - More from this issue of AIDS Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
